📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. (2016)

First Author: Arabi YM

Attributed to: International Severe Acute Respiratory and Emerging Infections Consortium funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3201/eid2209.151164

PubMed Identifier: 27532807

Publication URI: http://europepmc.org/abstract/MED/27532807

Type: Journal Article/Review

Volume: 22

Parent Publication: Emerging infectious diseases

Issue: 9

ISSN: 1080-6040